NCT02317003 (PEPPER) is a NA clinical trial of Intervention PPIL in Sedentary Lifestyle, sponsored by University Hospital, Angers.

Who is sponsoring NCT02317003?

NCT02317003 is sponsored by University Hospital, Angers.

What drugs are being tested in NCT02317003?

Interventions in NCT02317003: Intervention PPIL, Control OR.

What condition does NCT02317003 study?

NCT02317003 studies Sedentary Lifestyle, Cardiovascular Diseases, Hypertension, Hypercholesterolemia, Diabetes Mellitus, Type 2.

Is NCT02317003 still recruiting?

NCT02317003 is currently completed. Last updated 2 August 2022.

Last reviewed 2022-08-02 · How we verify

NCT02317003: PEPPER

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Physical Exercise Prescription With PEdometeR in General Practice for Patients With Cardiovascular Risk Factors - PEPPER

Completed NA Last updated 2 August 2022

What this trial tests

NA trial testing Intervention PPIL in Sedentary Lifestyle in 126 participants. Completed in 1 August 2018.

Timeline

16 March 2015

Primary endpoint
1 August 2018

1 August 2018

Quick facts

Lead sponsor	University Hospital, Angers
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	126
Start date	16 March 2015
Primary completion	1 August 2018
Estimated completion	1 August 2018
Sites	1 location across France

Drugs / interventions tested

Intervention PPIL
Control OR

Conditions studied

Sedentary Lifestyle — all drugs for Sedentary Lifestyle →
Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Hypertension — all drugs for Hypertension →
Hypercholesterolemia — all drugs for Hypercholesterolemia →

Sponsor

University Hospital, Angers

Who can join

Adults 35 to 74, any sex, with Sedentary Lifestyle or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the efficacy, in terms of energy expenditure, physical activity level, quality of life, blood pressure, waist circumference and weight, of a general practice based intervention involving a personalised physical exercise medical prescription, the structured delivery of information on the benefits of physical activity, a pedometer, and a pedometer log book, in 35 to 74 year old patients with cardiovascular risks factors.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Physical activity prescription for general practice patients with cardiovascular risk factors-the PEPPER randomised controlled trial protocol.
Missud DC, Parot-Schinkel E, Connan L, Vielle B, et al · · 2019 · cited 8× · PMID 31159805 · DOI 10.1186/s12889-019-7048-y
Comparing physical activity prescription with verbal advice for general practice patients with cardiovascular risk factors: results from the PEPPER randomised controlled trial.
Bellanger W, Peurois M, Connan L, Navasiolava N, et al · · 2023 · cited 1× · PMID 37475036 · DOI 10.1186/s12889-023-16302-6

Verify or expand the search:

Other recruiting trials for Sedentary Lifestyle

Currently open trials in the same condition.

NCT03511352 — Sedentary Behavior Interrupted: A Trial of Acute Effects on Biomarkers of Healthy Aging · NA · active not recruiting
NCT03356262 — The QUebec Adipose and Lifestyle InvesTigation in Youth (QUALITY) Cohort · active not recruiting

Other University Hospital, Angers trials

Trials by the same sponsor.

NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
NCT07470294 — Effectiveness of Different Surgical Techniques for Curative Treatment of Pilonidal Sinus Disease in the Pediatric Popula · not yet recruiting
NCT07409597 — Autobiographical Memory, Future Thought, and Eye Movements in Huntington's Disease · NA · not yet recruiting
NCT07468565 — Surgical Approach for the Treatment of Hirschsprung Disease Using the Swenson Technique (SMILES) · not yet recruiting
NCT07452952 — Relationship Between the Level of Positive End-expiratory Pressure and Venous Congestion During Acute Respiratory Distre · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02317003 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Angers
Last refreshed: 2 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02317003.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing